Paras Healthcare IPO GMP grey market premium, review, Subscription, allotment, listing estimate @ Chanakyanipothi.com,
*A legacy of 31 Years.
India`s Oldest Investment & IPO website.
*Most Trusted by Investors across India.
Table of Contents
- GMP
- Reviews
- Subscription
- Allotment
Latest news about Paras Healthcare IPO?
Applied or Avoid?
What is the latest GMP of Paras Healthcare IPO?
For latest GMP, Click
Subscription status of Paras Healthcare IPO
Paras Healthcare IPO SubscriptionsPrice Rs. ? Lot ? shares, Rs. ? Crore |
|||||
QIB | B HNI X | S HNI X | NII X | RII X | Total X |
Applications: ? / (?x) Amount wise Bids recd. Rs. ? Crore |
Who is the promoter of Paras Healthcare IPO?
DR. DHARMINDER KUMAR NAGAR is the promoter of Paras Healthcare ltd
What are the Objects of Paras Healthcare IPO?
The Offer comprises the Fresh Issue and offer for sale.
The Company proposes to utilise the Net Proceeds towards funding the following objects:
1. Prepayment or scheduled re-payment of a portion of certain outstanding borrowings availed by the Company.
2. Investment in its Subsidiaries, Paras Healthcare (Ranchi) Private Limited and Plus Medicare Hospitals Private Limited, in the form of debt or equity for repayment/prepayment of borrowings, in full or part, of such Subsidiaries
3. General corporate purposes
What is the business of Paras Healthcare?
Paras Healthcare is the fifth largest healthcare provider in terms of bed capacity in North India, Bihar and Jharkhand among its Peers, with an aggregate of 2,135 beds, as of March 31, 2024. It has eight hospitals that it operates under the “Paras Health” brand, which are spread across five states and one union territory in North India – Gurugram and Panchkula in Haryana; Patna and Darbhanga in Bihar; Kanpur, Uttar Pradesh; Udaipur, Rajasthan; Ranchi, Jharkhand; and Srinagar in the union territory of Jammu and Kashmir. Its core focus is on providing specialized tertiary medical care in Tier 2 and 3 cities, while seeking to strike a balance between providing quality healthcare services and affordability. It offers several clinical specialties across its hospitals including cardiac sciences, oncology, neuro sciences, gastro sciences and orthopedics and joint replacement. It has established centres of excellence across its hospitals, where it provides clinical specialties and these centres have been instrumental in launching new programs including organ transplant programs. Its extensive 18 years of experience in the healthcare industry in North India has helped it develop a strong understanding of the region’s market dynamics.
It has increased its bed capacity from 1,250 beds as of March 31, 2022 to 2,135 beds as of March 31, 2024 and it currently has a committed pipeline of hospital expansion in Gurugram and Ludhiana, which has been approved by its Board of Directors. In Gurugram, it is setting up another hospital through a long-term lease arrangement and it intends to launch this hospital in Fiscal 2027 with 300 beds. In Ludhiana, it is also setting up a hospital through a long-term lease arrangement and intend to launch it in Fiscal 2028 with up to 500 beds. The company expects that these expansion plans would increase its bed capacity from 2,135 as of March 31, 2024 to 2,935 by March 31, 2029.
As of March 31, 2024, it had a medical team of 1,091 doctors and 1,509 nurses. It has skilled clinicians at its hospitals who are experienced and well recognized in their fields having won several awards and accolades. In July 2017, Commelina Ltd (an affiliate of Creador, global private equity firm) acquired a stake in the Company.
For more information, click www.parashospitals.com
Paras Healthcare IPO GMP, Particulars & Guidance
Paras Healthcare IPO Details | |
IPO opens on | ? November 2024 |
IPO closes on | ? November 2024 |
Issue Type | Book Built Issue IPO |
Issue Size | ? Shares / Rs ? Crore |
* Fresh Issue | ? Shares / Rs 400 Crore |
* Offer for Sale | 14,974,010 Shares / Rs – Crore |
Face Value per share: | Rs. 1 |
Price Band | Rs. ? |
Retail Discount | Rs 0 per share |
Employee discount | Rs.? per share |
Retail Lot Size | ? Shares |
Listing will at | BSE, NSE |
Shares offered in Paras Healthcare? |
Shares | Rs. in Crore |
QIB (75 %) | ||
NII (15 %) | ||
RII (10 %) | ||
Employees | ||
Shareholders | ||
Retail portion will be oversubscribed by | ? Forms. | |
How to apply in Paras Healthcare IPO? | Amount Rs. |
|
Min Retail Application | ||
Max Retail Application | ||
Small HNI (Min) application | ||
Small HNI (Max) application | ||
Big HNI Application |
What is the timetable of Paras Healthcare IPO? |
|
IPO opens on | 2024 |
IPO Closes on | 2024 |
IPO Allotment on | 2024 |
Unblocking of ASBA | 2024 |
Credit of Shares | 2024 |
Listing on | 2024 |
Registered Office of Paras Healthcare | |
1st Floor, Tower B, Paras Twin Towers, Golf Course Road, Sector 54, Gurugram – 122 002, Haryana, India | |
Who are the Lead Managers of Paras Healthcare IPO? ICICI Securities Limited IIFL Securities Limited Motilal Oswal Investment Advisors Ltd |
|
Registrar to IPO | |
Link Intime India Private Limited |
Paras Healthcare IPO Financial & Analytical Ratios |
||||
Year | Total Income | Net Profit | EPS | RoNW |
Rs. in Cr | Rs.in Cr | Rs. | % | |
2021-22 | 793.17 | 14.81 | -2.01 | -18.37 |
2022-23 | 936.05 | 42.79 | -5.82 | -82.92 |
2023-24 | 1151.02 | 15.33 | -1.57 | -8.32 |
Book Value of the Share on 31.03.2024 |
Rs. | 34.68 | ||
BV of the Share after the FPO | Rs. | ? | ||
Offer Price at Cap | Rs. | ? |
Paras Healthcare IPO
|
|
Price /EPS | – |
Price/BV Ratio | – |
Price/BV after IPO | ? |
How Paras Healthcare IPO compares with the Peers?
As on the date of DRHP | FV | Total | PE |
Rs. | Income | Ratio | |
Rs. In Crore | |||
Paras Healthcare | 1 | 1129 | ? |
Apollo Hospital | 5 | 19059 | 106.63 |
Fortis Healthcare | 10 | 6893 | 64.29 |
Global Healthcare | 2 | 3275 | 67.64 |
Jupiter Lifeline | 10 | 1095 | 45.95 |
Krishna Medical | 10 | 2498 | 55.57 |
Max Healthcare | 10 | 6849 | 87.5 |
Narayan Hrydayalay | 10 | 5018 | 32.08 |
Yatharth Hospital | 10 | 670 | 31.97 |
# This is only coverage of News related to Grey Market. We do not deal in grey market premium, nor we recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.
Paras Healthcare IPO Guidance
This is the much-awaited IPO. Once the price band is finalized, we will provide our guidance.
Quicklinks
Paras Healthcare IPO GMP
Paras Healthcare IPO date review price
Paras Healthcare IPO GMP date review price allotment details